美国 · SEC FORM 4
ALIGN TECHNOLOGY INC
ALGN · Nasdaq · CIK 0001097149 · Healthcare · Medical Instruments & Supplies
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
10 同一窗口内观察到的 Form 4 交易行
0 sales · 10 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 4 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-08-01 · HOGAN JOSEPH M.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- -9.2%
- 3M
- -23.3%
- 6M
- -15.3%
- 12M
- —
波动率与流动性
- 波动率
- 39.5%
- Beta
- —
- 平均每日成交额
- —
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- 10.2%
- ROE
- 10.1%
- 细分行业
- Medical Instruments & Supplies
市场数据
价格数据截至:2026-10-02 · 价格来源:OpenBB/yfinance · 来自 SEC 申报文件:利润率, ROE · 财年截止日:2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 4,202,648
- 上期报告
- 3,901,037
- 日均成交量
- 976,621
- 回补天数
- 4.3
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-08-01 | HOGAN JOSEPH M | 买入 (P) | Common Stock | 7,576 | USD 131.49 | USD 996,168 | SEC 申报 ↗ |
| 2025-07-31 | Coletti Julie Ann | 买入 (P) | Common Stock | 42 | USD 109.66 | USD 4,606 | SEC 申报 ↗ |
| 2024-08-15 | LARKIN C RAYMOND JR | 买入 (P) | Common Stock | 6,500 | USD 235.33 | USD 1,529,645 | SEC 申报 ↗ |
| 2023-11-09 | HOGAN JOSEPH M | 买入 (P) | Common Stock | 5,194 | USD 192.50 | USD 999,845 | SEC 申报 ↗ |
| 2023-10-31 | HOGAN JOSEPH M | 买入 (P) | Common Stock | 5,319 | USD 188.00 | USD 999,972 | SEC 申报 ↗ |
| 2023-05-30 | Dallas Kevin J | 买入 (P) | Common Stock | 7,000 | USD 285.26 | USD 1,996,820 | SEC 申报 ↗ |
| 2023-02-08 | Morici John | 买入 (P) | Common Stock | 587 | USD 341.84 | USD 200,660 | SEC 申报 ↗ |
| 2023-02-08 | HOGAN JOSEPH M | 买入 (P) | Common Stock | 2,928 | USD 341.50 | USD 999,912 | SEC 申报 ↗ |
| 2022-11-02 | Thaler Warren S | 买入 (P) | Common Stock | 1,050 | USD 191.21 | USD 200,768 | SEC 申报 ↗ |
| 2022-11-02 | Myong Anne | 买入 (P) | Common Stock | 1,500 | USD 190.26 | USD 285,390 | SEC 申报 ↗ |
| 2022-11-02 | HOGAN JOSEPH M | 买入 (P) | Common Stock | 10,600 | USD 188.58 | USD 1,998,948 | SEC 申报 ↗ |
| 2022-05-13 | LARKIN C RAYMOND JR | 买入 (P) | Common Stock | 1,000 | USD 264.42 | USD 264,420 | SEC 申报 ↗ |
| 2022-05-04 | HOGAN JOSEPH M | 买入 (P) | Common Stock | 6,700 | USD 298.48 | USD 1,999,816 | SEC 申报 ↗ |
Form 4 申报证据
19 transaction lines in the latest 365-day window; 361 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Vitalone Britt J. | 期权行权/转换 (M) | Common Stock | 1,443 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Saia Andrea Lynn | 期权行权/转换 (M) | Common Stock | 1,745 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | SIEGEL SUSAN E | 期权行权/转换 (M) | Common Stock | 1,745 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (19 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Vitalone Britt J. | 期权行权/转换 (M) | Common Stock | 1,443 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Saia Andrea Lynn | 期权行权/转换 (M) | Common Stock | 1,745 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | SIEGEL SUSAN E | 期权行权/转换 (M) | Common Stock | 1,745 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Poul Mojdeh | 期权行权/转换 (M) | Common Stock | 1,745 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Myong Anne | 期权行权/转换 (M) | Common Stock | 1,745 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | MORROW GEORGE J | 期权行权/转换 (M) | Common Stock | 1,745 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | LARKIN C RAYMOND JR | 期权行权/转换 (M) | Common Stock | 2,326 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | LACOB JOSEPH | 期权行权/转换 (M) | Common Stock | 1,745 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Dallas Kevin J | 期权行权/转换 (M) | Common Stock | 1,745 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Conroy Kevin T | 期权行权/转换 (M) | Common Stock | 1,745 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-20 | Morici John | 期权行权/转换 (M) | Common Stock | 7,848 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-20 | Morici John | 代扣税 (F) | Common Stock | 2,549 | USD 190.02 | USD 484,361 | SEC 申报 ↗ |
| 2026-02-20 | Hockridge Stuart A | 期权行权/转换 (M) | Common Stock | 4,310 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-20 | Hockridge Stuart A | 代扣税 (F) | Common Stock | 1,210 | USD 190.02 | USD 229,924 | SEC 申报 ↗ |
| 2026-02-20 | HOGAN JOSEPH M | 期权行权/转换 (M) | Common Stock | 40,248 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-20 | HOGAN JOSEPH M | 代扣税 (F) | Common Stock | 16,107 | USD 190.02 | USD 3,060,652 | SEC 申报 ↗ |
| 2026-02-20 | Coletti Julie Ann | 期权行权/转换 (M) | Common Stock | 5,864 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-20 | Coletti Julie Ann | 代扣税 (F) | Common Stock | 1,718 | USD 190.02 | USD 326,454 | SEC 申报 ↗ |
| 2026-02-18 | Morici John | 卖出 (S) | Common Stock | 7,969 | USD 189.31 | USD 1,508,611 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ALGN |
| CIK | 0001097149 |
| 行业 | Healthcare |
| 细分行业 | Medical Instruments & Supplies Yahoo Finance |
| SEC SIC | 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 361 transaction lines from 2020-02-03 to 2026-05-20 15 P purchase lines · 158 S sale lines · 188 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.